An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER) cover art

An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)

An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)

Listen for free

View show details

About this listen

In this episode, we interview Sarah Emond, MPP, President and CEO of the Institute for Clinical and Economic Review (ICER). Sarah joined ICER over 15 years ago as Chief Operating Officer and was appointed to lead the organization following the retirement of Dr. Steven Pearson. Sarah outlines her vision for ICER and the priorities for strengthening the framework and collaboration to achieve their mission of evaluating the comparative effectiveness of new medicines. Sarah also discusses ICER’s efforts to expand patient engagement and the evaluation of payers to ensure fair access to medicine.

  • Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)
  • Dr. Steven Pearson, Founder, President, Institute for Clinical and Economic Review (ICER)
  • Barriers to Fair Access Report
  • Gross-to-Net Bubble
  • Pharmacy Benefit Managers (PBMs)
  • Humira biosimilars
  • Institute for Clinical and Economic Review (ICER)
  • 340B Drug Pricing Program

Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.

activate_mytile_page_redirect_t1

What listeners say about An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.